APOE and Alzheimer disease: We hope that more single-cell AD datasets become available from more brain regions and from diverse sets of individuals, across different ages, racial and ethnic backgrounds, with a greater diversity of APOE genotypes and disease severity, thus allowing for more extensive insights.